Suppr超能文献

直肠癌术前放疗:肿瘤降期及残留肿瘤细胞密度(RTCD)的预测因素:预后意义

Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.

作者信息

Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, Dorval E, de Calan L, Huten N, le Folch O, Calais G

机构信息

Clinique d'Oncologie et Radiothérapie, Hôpital Bretonneau, Tours, France.

出版信息

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):619-27. doi: 10.1016/s0360-3016(96)00577-9.

Abstract

PURPOSE

To determine predictive factors and prognostic value of tumor downstaging and tumor sterilization after preoperative RT for rectal cancer.

METHODS AND MATERIALS

Between 1977 and 1994, 167 patients with a histologically proven adenocarcinoma (70 T2, 65 T3, 29 T4, and 3 local recurrences) underwent preoperative RT. Median dose was 44 Gy (5-73 Gy). Surgery was performed in a mean time of 5 weeks after RT. Pathologic specimens have been reviewed by the same pathologist in order to specify the modified Astler Coller classification (MAC), and to quantify the residual tumor cell density (RTCD).

RESULTS

According to the MAC, there was 9 stage 0 (5%), 10 stage A (6%), 103 stage B1-B3 (62%), and 45 stage C1-C3 (27%) tumors. Seventeen percent and 56% of the patients who received a dose > or = 44 Gy had respectively a 0-A and a B tumor, compared to 4 and 69% in those who received a dose < 44 Gy (p = 0.04). Tumor differentiation and a longer interval before surgery were significantly associated with a more frequent downstaging, and preoperative staging correlated well to the postoperative pathological findings. According to the RTCD, 62 tumors (37%) showed no or only rare foci of residual tumor cells (Group 1); 62 (37%) showed an intermediate RTCD (Group 2); and 43 (26%) a high RTCD (Group 3). No predictive factor of RTCD was statistically significant. In univariate analysis, postoperative staging was a significant prognostic factor, with corresponding 5-year overall survival rates in 0-A, B, and C stages of 92, 67, and 26% (p < 0.01). RTCD was not a prognostic factor. However, overall and disease-free survival rates for patients with complete pathologic response of 83% at 2 and 5 years suggested a better outcome in this subgroup of patients.

CONCLUSION

The favorable influence of higher doses of preoperative RT on pathologic stage has been observed. Tumor differentiation, preoperative classification and time before surgery were the other predictive factors of tumor downstaging. However, there was no predictive factor of complete pathologic response. Even after preoperative RT, postoperative staging remained a prognostic factor.

摘要

目的

确定直肠癌术前放疗后肿瘤降期和肿瘤消除的预测因素及预后价值。

方法和材料

1977年至1994年间,167例经组织学证实为腺癌的患者(70例T2期、65例T3期、29例T4期和3例局部复发)接受了术前放疗。中位剂量为44 Gy(5 - 73 Gy)。放疗后平均5周进行手术。病理标本由同一位病理学家复查,以明确改良的阿斯特勒 - 科勒分类(MAC),并量化残余肿瘤细胞密度(RTCD)。

结果

根据MAC分类,有9例0期(5%)、10例A期(6%)、103例B1 - B3期(62%)和45例C1 - C3期(27%)肿瘤。接受剂量≥44 Gy的患者中,分别有17%和56%的患者肿瘤为0 - A期和B期,而接受剂量<44 Gy的患者中这一比例分别为4%和69%(p = 0.04)。肿瘤分化程度和手术前间隔时间较长与更频繁的降期显著相关,术前分期与术后病理结果相关性良好。根据RTCD,62例肿瘤(37%)显示无或仅有罕见的残余肿瘤细胞灶(第1组);62例(37%)显示中等RTCD(第2组);43例(26%)显示高RTCD(第3组)。RTCD的预测因素均无统计学意义。单因素分析中,术后分期是一个显著的预后因素,0 - A期、B期和C期患者相应的5年总生存率分别为92%、67%和26%(p < 0.01)。RTCD不是预后因素。然而,完全病理缓解患者的2年和5年总生存率及无病生存率分别为83%,提示该亚组患者预后较好。

结论

已观察到较高剂量术前放疗对病理分期有有利影响。肿瘤分化程度、术前分类和手术前时间是肿瘤降期的其他预测因素。然而,完全病理缓解没有预测因素。即使经过术前放疗,术后分期仍然是一个预后因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验